| John Bursch, | |
|
300 Midtown Dr, Beaufort, SC 29906-5200 | |
| (843) 521-1747 | |
| Not Available |
| Full Name | John Bursch |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 300 Midtown Dr, Beaufort, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215044474 | NPI | - | NPPES |
| 1288 | Other | SC | LICENSE # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| John Bursch, 345 Cottage Farm Dr, Beaufort, SC 29902-5971 Ph: (343) 522-9914 | John Bursch, 300 Midtown Dr, Beaufort, SC 29906-5200 Ph: (843) 521-1747 |
News Archive
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that aldoxorubicin has received orphan medicinal product designation from the European Commission for the treatment of advanced soft tissue sarcomas. The designation is to encourage the development of drugs which may provide significant benefit to patients suffering from rare diseases.
Psoriasis is a long-lasting autoimmune disease that is characterized by patches of abnormal and inflamed skin. It is generally thought to have a genetic origin, which can be further triggered by environmental factors. People with specific mutations in the CARD14 gene have a high probability of developing psoriasis.
A Loyola University Hospital study has demonstrated how the hospital has improved patient safety and cut costs by reducing the number of blood transfusions.
The Singaporean government's emphasis on raising awareness on the benefit of frequent health check-ups have significantly raised the number of Hepatitis C Virus (HCV) diagnosed cases in the country, expanding the patient pool. Therapeutics companies have a challenging task ahead for improving treatment for this market as current treatment requires high dosage frequency, but potentially has serious side effects.
Cell Therapeutics, Inc. today announced it has filed for a Special Protocol Assessment ("SPA") with the U.S. Food and Drug Administration ("FDA") for the design of its new phase III trial of pixantrone for patients with relapsed or refractory aggressive B-Cell non-Hodgkin's lymphoma ("NHL").
› Verified 4 days ago
Raymond Cross, PT DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1 Pinckney Blvd, Beaufort, SC 29902 Phone: 843-228-1318 | |
Michael Wayne Twitty, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1076 Ribaut Rd Ste 102, Beaufort, SC 29902 Phone: 843-521-1970 Fax: 843-521-0908 | |
Michael George Konoza, MSPT, ATC Physical Therapist Medicare: May Accept Medicare Assignments Practice Location: 1076 Ribaut Rd, Suite102, Beaufort, SC 29902 Phone: 843-521-1970 Fax: 843-521-0908 | |
Carla Marshall Carson, MSPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1076 Ribaut Rd, Suite 102, Beaufort, SC 29902 Phone: 843-521-1970 | |
Brooke Gottlieb, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 18 Professional Village Cir, Beaufort, SC 29907 Phone: 843-986-9670 | |
Mr. Aaron Stoll, PT, ATC Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Pinckney Blvd., Naval Hospital Beaufort, Beaufort, SC 29902 Phone: 843-228-5577 Fax: 843-228-5196 | |
Ann Marie Tullock, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1076 Ribaut Rd Ste 102, Beaufort, SC 29902 Phone: 843-521-1970 |